USPTO serial 77763300
FORTESTA
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- JENKINS JR, CHARLES L
- Law office
- OFFICE OF TRADEMARK PROGRAM CONTROL
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FORTESTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Galashiels TD1 1QH, GB
Galashiels TD1 1QH, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Margaret McHugh
MARGARET MCHUGH TOWNSEND AND TOWNSEND AND CREW LLP2 EMBARCADERO CTR FL 8SAN FRANCISCO, CA 94111-3833UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders, hormone deficiencies, skin diseases, skin disorders, bone diseases, bone disorders, sexually transmitted diseases, diseases of the central nervous system, cancer, microbial conditions and infections, rectal conditions, rectal diseases and rectal disorders, vitamin and mineral deficiencies, pain, gastro-intestinal conditions, and cardiovascular conditions; pharmaceutical preparations, substances and gels for hormone replacement; sanitary preparations for medical use; dietetic foods and dietetic food supplements adapted for medical use; medical plasters; materials for dressings, namely, burn dressings, surgical dressings, and wound dressings; gauzes and bandages for dressings; transdermal patches containing pharmaceutical preparation for the treatment of metabolic disorders, hormone deficiencies, skin diseases, skin disorders, bone diseases, bone disorders, sexually transmitted diseases, diseases of the central nervous system, cancer, microbial conditions and infections, rectal conditions, rectal diseases and rectal disorders, vitamin and mineral deficiencies, pain, gastro-intestinal conditions, and cardiovascular conditions; transdermal gel for hormone therapy; testosterone gel; hormone preparations for the treatment of hypogonadism; pharmaceutical preparations for the treatment of diabetes, insulin resistance and metabolic syndrome | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 10, 2009 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Nov 10, 2009 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 3, 2009 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 26, 2009 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Sep 29, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 29, 2009 | ALIE | ASSIGNED TO LIE | — |
| Sep 17, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 22, 2009 | NWAP | NEW APPLICATION ENTERED | — |